Cell cycle-dependent stimulation of the HIV-1 promoter by Tat-associated CAK activator

Virology

Volumn 266, Issue 2, 2000, Pages 246-256

  Nekhai, Sergei ^a   Shukla, Ram R ^a   Fernandez, Anne ^b   Kumar, Ajit ^a   Lamb, Ned J C ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; RAS PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL CYCLE; CELL GROWTH; CELL SYNCHRONIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MITOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN RNA BINDING; SIGNAL TRANSDUCTION; TRANSACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034688295     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0035     Document Type: Article

References (58)

1. Adams M., Sharmeen L., Kimpton J., Romeo J. M., Garcia J. V., Peterlin B. M., Groudine M., Emerman M. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA. 91:1994;3862-3866.
2. Ascher M. S., Sheppard H. W., Krowka J. F., Bremermann H. J. AIDS as immune system activation. Key questions that remain. J. Adv. Exp. Med. Biol. 374:1995;203-210.
3. Boris-Lawrie K., Brady J., Kumar A. Sequences within the R region of the long terminal repeat activate basal transcription from the HIV-1 promoter. Gene Expression. 2:1992;215-229.
4. Bukrinsky M. I., Stanwick T. L., Dempsey M. P., Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science. 254:1991;423-427.
5. Cadena D., Dahmus M. J. Messenger RNA synthesis in mammalian cells is catalyzed by the phosphorylated form of RNA polymerase II. J. Biol. Chem. 262:1987;12468-12474.
6. Cai H., Szeberenyi J., Cooper G. M. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10:1990;5314-5323.
7. Chun R. F., Jeang K. T. Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J. Biol. Chem. 271:1996;27888-27894.
8. Cujec T. P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D. O., Peterlin B. M. The HIV transactivator Tat binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1997;2645-2657.
9. Cullen B. R. HIV-1 auxiliary proteins: Making connections in a dying cell. Cell. 93:1998;685-692.
10. Dobrowolski S., Harter M., Stacey D. W. Cellular ras activity is required for passage through multiple points of G0/G1 phase in BALB/c 3T3 cells. Mol. Cell. Biol. 14:1994;5441-5449.
11. Fauci A. S. Host factors and pathogenesis of HIV-induced disease. Nature. 384:1996;529-534.
12. Feaver W. J., Svejstrup J. Q., Henry N. L., Kornberg R. D. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell. 79:1994;1103-1109.
13. Fisher R. P., Morgan D. O. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell. 78:1994;713-724.
14. Fisher R. P., Jin P., Chamberlin H. M., Morgan D. O. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell. 83:1995;47-57.
15. Garber M. D., Wei P., Kewal-Ramani V. N., Mayall T. P., Herrmann C. H., Rice A. P., Littman D. R., Jones K. A. The interaction between HIV-Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12:1998;3512-3527.
16. Garcia-Martinez L. F., Mavankal G., Neven J., Lane W. S., Ivanov D., Gaynor R. B. Purification of Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:1997;2836-2850.
17. Gaynor R. B. Regulation of HIV-1 gene expression by the transactivator protein Tat. Curr. Top. Microbiol. Immunol. 193:1995;51-77.
18. Gerber H. P., Hagmann M., Seipel K., Georgiev O., West M. A., Litingtung Y., Schaffner W., Corden J. L. RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature. 374:1995;660-662.
19. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1995;1766-1769.
20. Herrmann C. H., Rice A. P. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxy-terminal domain of the large subunit RNA polymerase II: Candidate for a Tat cofactor. J. Virol. 69:1995;1612-1620.
21. Herrmann C. H., Gold M. O., Rice A. P. Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain. Nucleic Acids Res. 24:1996;501-508.
22. Hillen W., Berens C. Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol. 48:1994;345-369.
23. Jones K. A., Peterlin B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:1994;717-743.
24. Kato J. Y., Sherr C. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA. 90:1993;11513-11517.
25. Keen N. J., Gait M. J., Karn J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl. Acad. Sci. USA. 93:1996;2505-2510.
26. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66:1992;2232-2239.
27. Laspia M. F., Rice A. P., Mathews M. B. HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation. Cell. 59:1989;283-292.
28. Lu H., Flores O., Weinmann R., Reinberg D. The nonphosphorylated form of RNA polymerase II preferentially associates with the preinitiation complex. Proc. Natl. Acad. Sci. USA. 88:1991;10004-10008.
29. Lu H., Zawel L., Fisher L., Egly J.-M., Reinberg D. Human general transcription factor II H phosphorylates the C-terminal domain of RNA polymerase II. Nature. 358:1992;641-645.
30. Marciniak R. A., Sharp P. A. HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J. 10:1991;4189-4196.
31. Mavankal G., Ou S. I., Oliver H., Sigman D., Gaynor R. B. HIV-1 and HIV-2 Tat proteins specifically interact with RNA polymerase II. Proc. Natl. Acad. Sci. USA. 93:1996;2089-2094.
32. Mulcahy L. S., Smith M. R., Stacey D. W. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature. 313:1985;241-243.
33. Nekhai S., Shukla R. R., Kumar A. A human primary T-lymphocyte-derived human immunodeficiency virus type 1 Tat-associated kinase phosphorylates the C-terminal domain of RNA polymerase II and induces CAK activity. J. Virol. 71:1997;7436-7441.
34. Nekhai, S, Lane, W. S, and, Kumar, A. 1999, HIV-1 Tat-associated CAK activator is PSTAIRE-like kinase which phosphorylates CDK7. In preparation.
35. O'Brien T., Hardin S., Greenleaf A., Lis J. T. Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature. 370:1994;75-77.
36. Okamoto H., Sheline C. T., Corden J. L., Jones K. A., Peterlin B. M. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA. 93:1996;11575-11579.
37. Parada C. A., Roeder R. G. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature. 384:1996;375-378.
38. Pardee A. B. G1 events and regulation of cell proliferation. Science. 246:1989;603-608.
39. Payne J. M., Dahmus M. E. Partial purification and characterization of two distinct protein kinases that differentially phosphorylate the carboxy-terminal domain of RNA polymerase subunit IIa. J. Biol. Chem. 268:1993;80-87.
40. Peeper D. S., Upton T. M., Ladha M. H., Newman E., Zalvide J., Bernards R., DeCaprio J. A., Ewen M. E. Ras signaling linked to the cell-cycle machinery by the retinoblastoma protein. Nature. 386:1997;177-181.
41. Peng J., Zhu Y., Milton J. T., Price D. H. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:1998;755-762.
42. Rounseville M. P., Kumar A. Binding of a host cell nuclear protein to the stem region of human immunodeficiency virus type 1 trans-activation-responsive RNA. J. Virol. 66:1992;1688-1694.
43. Roy R., Adamczewski J. P., Seroz T., Vermeulen W., Tassan J. P., Schaeffer L., Nigg E. A., Hoeijmakers J. H., Egly J.-M. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell. 79:1994;1093-1101.
44. INK4. Science. 267:1995;249-252.
45. Sherr C. J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
46. Sherr C. J., Roberts J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
47. Shiekhattar R., Mermelstein F., Fisher R. P., Drapkin R., Dynlacht B., Wessling H. C., Morgan D. O., Reinberg D. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature. 374:1995;283-287.
48. Tassan J.-P., Jaquenoud M., Fry A. M., Frutiger S., Hughes G. J., Nigg E. A. In vivo assembly of a functional human CDK7-cyclin H complex requires MAT 1, a novel 36 kDa RING finger protein. EMBO J. 14:1995;5608-5617.
49. Wei P., Garber M. E., Fang S. M., Fischer W. H., Jones K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR-RNA. Cell. 92:1998;451-462.
50. Xiong Y., Hannon G. J., Zhang H., Casso D., Kobayashi R., Beach D. P21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
51. Yang X., Herrmann C. H., Rice A. P. The human immunodeficiency virus Tat protein specifically associates with TAK in vivo and requires the carboxyl-terminal domain of RNA polymerase II for function. J. Virol. 70:1996;4576-4584.
52. Yankulov K., Blau J., Purton T., Roberts S., Bentley D. L. Transcriptional elongation by RNA polymerase II is stimulated by transactivators. Cell. 77:1994;749-759.
53. Zack J. A., Arrigo S. J., Weitsman S. R., Go A. S., Haislip A., Chen I. S. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell. 61:1990;213-222.
54. Zawel L., Reinberg D. Common themes in assembly and function of eukaryotic transcription complexes. Annu. Rev. Biochem. 64:1995;533-561.
55. Zhou A., Sharp P. A. Tat-SF1: Cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science. 274:1996;605-610.
56. Zhou Q., Sharp P. A. Novel mechanism and factor for regulation of HIV-1 Tat. EMBO J. 14:1995;321-328.
57. Zhou Q., Chen D., Pierstorff E., Luo K. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J. 17:1998;3681-3691.
58. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Amendt B., Mathews M. B., Price D. H. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:1997;2622-2632.